Heisenberg Group for applied Matrixbiology and translational fibrosis research

Medicine 3

Head of Department:
Prof. Dr. med. univ. Georg Schett

The impact of fibroblasts in sclerodermia and rheumatoid arthritis

Head: Prof. Dr. med. Jörg Distler

Fibrotic diseases account for up to 45% of deaths in the developed world, yet there are almost no effective anti-fibrotic therapies for clinical use.

In our research group, we aim to investigate the molecular mechanisms underlying the aberrant tissue responses in fibrotic diseases (such as systemic sclerosis/scleroderma, chronic Graft-versus-Host-disease, pulmonary fibrosis, liver cirrhosis, renal fibrosis and hypertrophic scars) and to develop novel strategies for therapeutic intervention.

Our strategy is to identify de-regulated signaling pathways in samples of human fibrotic diseases ex vivo, to characterize their regulation and function in vitro and in vivo and to evaluate their potential for therapeutic intervention in murine models. Our evaluation included novel optical imaging strategies, which we run in close cooperation with the Max-Planck Institute of the Science of Light (Immunophysics).

Promising novel therapeutic approaches are transferred from bench-to-bedside with evaluation of the novel pharmacologic approach in clinical trials in patients with fibrotic diseases, often in cooperation with pharmaceutical industry.

Selected Publications of Prof. Dr. Jörg Distler

 
Contact
Prof. Dr. med. Jörg Distler
business card

Staff:

Jörg Distler
Christina Bergmann
Alina Soare
Chih-Wei Chen
Clara Dees
Sebastian Pötter
Ariella Zehender
Ruifang Liang
Debomita Chakraborty
Lena Summa
Markus Luber
Wolfgang Espach
Xiaohan Xu
Thuong Trinh-Minh
Andrea-Hermina Györfi
Alexandru-Emil Matei
Yun Zhang
Vladyslav Fedorchenko
Ludwig Hallenberger
Benita Merlevede
Katja Dreißigacker (in maternity leave)
Regina Kleinlein


 
 
 
 
Please insert your name and correct email addresses!
X zum Schließen

Summary